# Extended Post-operative Oral TXA in Primary THA

> **NCT07685743** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Oregon Health and Science University** · enrollment: 170 (estimated)

## Conditions studied

- Osteoarthritis (OA) of the Hip
- Osteoarthritis (OA) of the Knee

## Interventions

- **DRUG:** Extended oral tranexamic acid regimen
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07685743
- **Lead sponsor:** Oregon Health and Science University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09-01
- **Primary completion:** 2028-03-01
- **Final completion:** 2028-09-01
- **Target enrollment:** 170 (ESTIMATED)
- **Last updated:** 2026-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07685743

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07685743, "Extended Post-operative Oral TXA in Primary THA". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07685743. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*